GHRHR and skin cancer: Although both GHRHR and SV1 are present in prostatic (45), breast (46), gastric (27), ovarian (47), pancreatic (37), lung (48), esophageal (17), oral (38, 49), and skin cancers (50), SV1 possess stronger mitogenic activities (36, 39, 40).